Healthcare IT Today April 25, 2024
Latest Investment Will Support the Democratization of Precision Medicine Through the Advancement of Novel Explainable AI Algorithms
Zephyr AI, Inc. (Zephyr AI), a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) solutions to democratize precision medicine, today announced it has successfully closed a $111 million Series A funding round with participation from Revolution Growth, Eli Lilly & Company, Jeff Skoll, and EPIQ Capital Group, among others. The company is developing improved data federation tools along with various machine learning algorithms in the areas of oncology and cardiometabolic disease.
“The US has the highest rate of avoidable cancer and cardiometabolic-related deaths among any high-income country. We must do better,” said Grant Verstandig, Zephyr AI’s Co-Founder and Executive...
Today's Sponsors
Today's Sponsor